Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2-Week vs 3-Week XELOX Adjuvant Chemotherapy in Colorectal Cancer
NCT03564912Phase 2Completed
- Sponsor
- Zhejiang University
- Start
- Aug 2018
- Primary completion
- Aug 2021
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, oxaliplatin in colorectal cancer (CRC), sponsored by Zhejiang University. Started Aug 2018; status: completed.
02
Drugs
capecitabineoxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03564912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03564912.